(PharmaNewsWire.Com, September 28, 2017 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Cell Therapy in these regions, from 2012 to 2022 (forecast) , covering North America Europe China Japan Southeast Asia India Global Cell Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Dendreon Mesoblast Vericel AlloCure Amorcyte Anterogen Antibe Therapeutics Astellas Pharma Athersys Avita Medical AxoGen Bellicum Pharmaceuticals BioCardia BIOCELLULAR THERAPIES Biogen Idec Bio-Tissue BIOTIME BioTissue Technologies BrainStorm Cell Therapeutics Bluebird Bio Bone Therapeutics Caladrius Capricor Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Nanotechnology Natural Substances On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales) , market share and growth rate of Cell Therapy for each application, including Scientific Research Hospital Other
2 Global Cell Therapy Market Competition by Manufacturers
3 Global Cell Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)
4 Global Cell Therapy Supply (Production) , Consumption, Export, Import by Region (2012-2017)
5 Global Cell Therapy Production, Revenue (Value) , Price Trend by Type
6 Global Cell Therapy Market Analysis by Application
7 Global Cell Therapy Manufacturers Profiles/Analysis 7.1 Dendreon 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Cell Therapy Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Dendreon Cell Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Mesoblast 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Cell Therapy Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Mesoblast Cell Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Vericel 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Cell Therapy Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Vericel Cell Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview 7.4 AlloCure 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Cell Therapy Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 AlloCure Cell Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Amorcyte 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Cell Therapy Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Amorcyte Cell Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.5.4 Main Business/Business Overview
8 Cell Therapy Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
